Why is Venus Remedies falling/rising?

As of 29-Aug, Venus Remedies Ltd is currently priced at 459.40, reflecting a decrease of 2.6 points or 0.56%. The stock has been underperforming recently, having fallen consecutively for the last four days, resulting in a total decline of 8.93% over the past week. It opened today with a loss of 2.58% and reached an intraday low of Rs 447, indicating significant selling pressure. Despite this short-term decline, the stock has shown strong performance over the longer term, with a year-to-date increase of 45.77% and a remarkable 372.15% rise over the past five years. The company has demonstrated solid fundamentals, including a low debt-to-equity ratio and positive quarterly results, which may contribute to its appeal despite the recent price drop.
In the broader market context, Venus Remedies has underperformed the Sensex, which has declined by only 1.84% over the past week. While the stock's short-term performance is disappointing, it has outperformed the benchmark over longer periods, such as the last year and three years. The increase in institutional investor participation, with a 1.01% rise in their stake, suggests confidence in the company's fundamentals, which could provide some support for the stock in the future. However, the recent price movements indicate that market sentiment may be influenced by short-term trading dynamics rather than long-term fundamentals.